SCHEMBL7699322

SCHEMBL7699322

Clc1cccc(Nc2cnc3cc4ccccc4cc3n2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 6/20 0.71
PDGFRA P16234 6/20 0.71
IGF1R P08069 1/20 0.55
HTR3E A5X5Y0 1/20 0.50
HTR3B O95264 1/20 0.50
HTR3A P46098 1/20 0.50
ROCK1 Q13464 1/20 0.50
HTR3D Q70Z44 1/20 0.50
HTR3C Q8WXA8 1/20 0.50
ABCG2 Q9UNQ0 2/20 0.49
ABCB1 P08183 1/20 0.49
ABCC1 P33527 1/20 0.49
FADS1 O60427 3/20 0.48
EGFR P00533 3/20 0.47
ERBB3 P21860 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
KDR P35968 1/20 0.46
PDE5A O76074 2/20 0.46
RHOA P61586 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3952287 0.88 PDGFRB (0.68) PDGFRBPDGFRAIGF1RHTR3EHTR3B
SCHEMBL7696498 0.87 PDGFRB (0.55) PDGFRBPDGFRAIGF1RHTR3EHTR3B
SCHEMBL6213709 0.87 PDGFRB (0.74) PDGFRBPDGFRAIGF1RHTR3EHTR3B
SCHEMBL7695393 0.85 PDGFRB (0.59) PDGFRBPDGFRAABCG2EGFRERBB3
SCHEMBL7696400 0.84 PDGFRB (0.76) PDGFRBPDGFRAABCG2MEN1KMT2A
SCHEMBL3911063 0.83 PDGFRB (1.00) PDGFRBPDGFRAEGFRERBB3MEN1
SCHEMBL7694543 0.82 PDGFRB (0.52) PDGFRBPDGFRAIGF1RKMT2AKDR
SCHEMBL7697848 0.82 PDGFRB (0.56) PDGFRBPDGFRAABCG2ABCC1EGFR
SCHEMBL7691917 0.82 PDGFRB (0.56) PDGFRBPDGFRAABCG2ABCB1ABCC1
SCHEMBL7699307 0.82 PDGFRB (0.56) PDGFRBPDGFRAIGF1RABCG2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 WO disclosed